The unsurprising story of MDR-TB resistance in India (Q34637486)

3 August 2017

title

The unsurprising story of MDR-TB resistance in India (English)

1 reference

3 August 2017

0 references

Giridhara R Babu

1

0 references

Ramanan Laxminarayan

series ordinal

2

object named as

Ramanan Laxminarayan

1 reference

3 August 2017

publication date

14 April 2012

1 reference

3 August 2017

1 reference

3 August 2017

volume

92

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

301-306

1 reference

Totally drug-resistant tuberculosis in India.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

India reports cases of totally drug-resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

XDR-TB: Indian perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

An immeasurable crisis? A criticism of the millennium development goals and why they cannot be measured

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

Viewpoint: do we have enough data to estimate the current burden of tuberculosis? The example of Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

How to measure the prevalence of tuberculosis in a population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

Size and usage patterns of private TB drug markets in the high burden countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

XDR-TB in South Africa: no time for denial or complacency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

XDR-TB in South Africa: detention is not the priority

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

Natural ventilation for the prevention of airborne contagion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

"Opportunities for improving public health system in India" analysis of current state of affairs and pointers for future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2012.02.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2012.02.009

1 reference

3 August 2017

1 reference